机译:Pembrolizumab在先进的软组织肉瘤和骨肉瘤(SARC028):多期,双队,单臂,开放标签,第2期试验
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Pittsburgh Pittsburgh PA USA;
Canc Res &
Biostat Seattle WA USA;
Washington Univ Sch Med St Louis MO USA;
Univ Michigan Ann Arbor MI 48109 USA;
Univ Southern Calif Los Angeles CA USA;
Mem Sloan Kettering Canc Ctr New York NY 10021 USA;
Mayo Clin Jacksonville FL 32224 USA;
Duke Univ Durham NC USA;
MedStar Washington Hosp Ctr Washington Canc Inst Washington DC USA;
Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;
Oregon Hlth &
Sci Univ Portland OR 97201 USA;
Mayo Clin Jacksonville FL 32224 USA;
H Lee Moffitt Canc Ctr &
Res Inst Tampa FL USA;
Canc Res &
Biostat Seattle WA USA;
Univ Pittsburgh Pittsburgh PA USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
Univ Michigan Ann Arbor MI 48109 USA;
Hofstra Northwell Sch Med Hempstead NY USA;
Sarcoma Alliance Res Collaborat Ann Arbor MI USA;
Univ Texas MD Anderson Canc Ctr Houston TX 77030 USA;
机译:Pembrolizumab在先进的软组织肉瘤和骨骼肉瘤(SARC028):多期,双队,单臂,开放标签,第2阶段试验(Vol 18,PG 1493,2017)
机译:Doxorubicin Plus evofosfamide与多柔比霉素单独在局部先进,不可切除或转移性组织Sarcoma(Th CR-406 / SARC021):国际,多期中心,开放标签,随机阶段3试验(Vol 18,PG 1089,2017)
机译:Doxorubicin Plus evofosfamide与多柔比蛋白单独在局部先进,不可切除或转移软组织Sarcoma(Th CR-406 / SARC021):国际,多方形,开放标签,随机阶段3试验
机译:在原发性人类软组织肉瘤切除术中测量微剂量ABY-029荧光信号
机译:测试生长骨骼中的小儿肌肉骨骼肉瘤疗法的预测模型系统的概念开发
机译:Cixutumumab和西罗莫司的患者骨与软组织肉瘤的多中心开放性Ⅱ期临床试验
机译:西妥昔单抗和替西罗莫司用于骨肉瘤和软组织肉瘤的患者:一项多中心,开放标签的2期试验